Basic Information
The LIT™ platform developed by Seroxo can provide rapid, reliable, and easy-to-use cancer and sepsis detection using a single drop of blood from the fingertip. LIT™ is transforming the diagnostics landscape and solidifying Seroxo's position as a world leader in the IVD field.
Seroxo Ltd.
London,England,United Kingdom
unclear
--
info@seroxo.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios